Orthofix Medical (OFIX) Revenue (2010 - 2026)

Orthofix Medical has disclosed Revenue across 17 years of filings, most recently posting $186.1 million for Q1 2026.

• Quarterly Revenue rose 2.47% year-over-year to $186.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $791.2 million (up 6.81% YoY) and the FY2025 annual result came in at $822.3 million, up 9.97% from the prior year.
• Revenue declined to $186.1 million in Q1 2026, from $219.9 million in the prior quarter.
• Over five years, Revenue peaked at $219.9 million in Q4 2025 and troughed at $67.0 million in Q4 2022.
• A 5-year average of $161.9 million and a median of $175.8 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue sank 39.32% — and 2023, when it soared 119.73%.
• Tracing OFIX's Revenue over 5 years: stood at $67.0 million in 2022, then surged by 119.73% to $147.1 million in 2023, then advanced by 11.44% to $163.9 million in 2024, then surged by 34.13% to $219.9 million in 2025, then fell by 15.37% to $186.1 million in 2026.
• Business Quant data shows OFIX's Revenue at $186.1 million in Q1 2026, $219.9 million in Q4 2025, and $193.8 million in Q3 2025.